Hanmei Lou

机构：Chinese Academy of Sciences, Zhejiang Cancer Hospital, Cancer Hospital of Chinese Academy of Medical Sciences, University of Chinese Academy of Sciences, Hangzhou Cancer Hospital · ORCID：0000-0003-4314-3426

发表论文 57 篇 · 总被引 345 次 · h-index 11

代表论文

• Bulumtatug Fuvedotin (BFv, 9MW2821), a next-generation Nectin-4 targeting antibody–drug conjugate, in patients with advanced solid tumors: a first-in-human, open-label, multicenter, phase I/II study (2025 · Annals of Oncology · 被引 27)
• Stromal score is a promising index in tumor patients’ outcome determination (2023 · Heliyon · 被引 17)
• HPV‐related cervical diseases: Alteration of vaginal microbiotas and promising potential for diagnosis (2022 · Journal of Medical Virology · 被引 14)
• Review of radiotherapy for cervical cancer (2025 · Holistic Integrative Oncology · 被引 5)
• Predictors of distant metastasis or local recurrent after radiotherapy in patients with cervical cancer (2025 · BMC Cancer · 被引 5)
• Plasma-based proteomic and metabolomic characterization of lung and lymph node metastases in cervical cancer patients (2024 · Journal of Pharmaceutical and Biomedical Analysis · 被引 4)